Physician

Derek Berberian, MD

According to 2025 Medicare claims, Derek Berberian, MD (NPI: 1346597200) practices neuropsychiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is NORTH JERSEY HEALTH AND WELLNESS LLC (NPI: 1285005884) and primary practice location at 07652-5237.

Berberian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 104 traditional Medicare patients, billed 1,278 HCPCS/CPT codes, and received $134,814 in Medicare payments. The top billing code was 90792 (Psychiatric diagnostic evaluation with medical services). Part D data shows 851 prescription claims across 69 beneficiaries totaling $360,588 in drug costs, led by Spravato (Esketamine Hcl). Open Payments data shows 102 records totaling $1,817. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $69,757 to $134,814. Similarly, Part D prescription costs have risen steadily, from $167 to $360,588. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$110K$220K2016 Medicare payment: $69,757 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $154,872 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $68,129 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $99,520 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $118,374 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $179,501 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $196,669 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $219,536 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $134,814 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201644856$69,757
20171862,050$154,872
201890941$68,129
2019981,038$99,520
20201071,249$118,374
20211641,909$179,501
20221662,017$196,669
20231762,310$219,536
20241041,278$134,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$180K$361K2015 Drug cost: $167 (USD; Tot_Drug_Cst)2016 Drug cost: $5,724 (USD; Tot_Drug_Cst)2017 Drug cost: $57,162 (USD; Tot_Drug_Cst)2018 Drug cost: $48,353 (USD; Tot_Drug_Cst)2019 Drug cost: $37,048 (USD; Tot_Drug_Cst)2020 Drug cost: $43,269 (USD; Tot_Drug_Cst)2021 Drug cost: $91,876 (USD; Tot_Drug_Cst)2022 Drug cost: $151,582 (USD; Tot_Drug_Cst)2023 Drug cost: $214,217 (USD; Tot_Drug_Cst)2024 Drug cost: $360,588 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R12$167
201624188$5,724
201782851$57,162
201871788$48,353
201972762$37,048
202084896$43,269
202185853$91,876
202277751$151,582
202377735$214,217
202469851$360,588

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90792Psychiatric diagnostic evaluation with medical services1515$137
90837Psychotherapy, 1 hour42832$124
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3258$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more54159$67
90833Psychotherapy with evaluation and management visit, 30 minutes47159$57

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SpravatoEsketamine Hcl49378$67,778
MounjaroTirzepatide511,812$64,389
Nurtec OdtRimegepant Sulfate21612$40,316
VraylarCariprazine Hcl16480$22,631
OzempicSemaglutide16460$15,189

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.102$1,817Supernus Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Derek Berberian, MD?

Tedicare shows public-source Medicare data for Derek Berberian, MD (NPI 1346597200), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Derek Berberian, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Derek Berberian, MD?

Derek Berberian, MD is linked to NORTH JERSEY HEALTH AND WELLNESS LLC (billing NPI 1285005884) in the available physician profile data.

Does Derek Berberian, MD have Open Payments data?

Derek Berberian, MD has 102 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.